Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Self-Hypnosis for Intrapartum Pain management (SHIP) trial
ISRCTN ISRCTN27575146
ClinicalTrials.gov identifier
Public title Self-Hypnosis for Intrapartum Pain management (SHIP) trial
Scientific title Self-Hypnosis for Intrapartum Pain management (SHIP): a single organisation, two-site pragmatic exploratory non-blinded randomised controlled trial with blinded analysis based on intention to treat, and contextualised by interviews, focus groups, logs, and questionnaires
Acronym SHIP Trial
Serial number at source PB-PG-0808-16234
Study hypothesis There will be no difference in rates of epidural usage in labour for maternal request between women randomised to an antenatal group self-hypnosis programme and those randomised to usual care.
Lay summary
Ethics approval 1. NHS IRAS Ethics Committee System approved
2. University of Central Lancashire Faculty of Health Ethics Committee approved
Study design Multicentre pragmatic exploratory non-blinded randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Intrapartum maternity care
Participants - inclusion criteria All nulliparous women who:
1. Have a singleton, viable, cephalic pregnancy
2. Are planning a vaginal birth in hospital
3. Have no current history of being under treatment for psychiatric disorders or of hypertensive disorders
4. Speak and read English
5. Consent to take part
6. Who are available to attend the intervention sessions
7. Aged between 18 and 45 years
Participants - exclusion criteria Does not meet the inclusion criteria
Anticipated start date 01/08/2010
Anticipated end date 31/07/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 800
Interventions Intervention group:
1. Each group hypnosis programme will be provided by one of 4 midwives with appropriate training
2. They will not be present during the labour and birth of study participants
3. The programmes will be provided in addition to usual care
4. Each programme will be delivered on one of the two Trust sites, with evening or weekend options, to groups of 5 - 10 women and their planned birth companions (a total maximum of 20 people) in 2 sessions separated by 3 weeks (32 weeks gestation, 35 weeks gestation
5. Each session will last 90 minutes
6. Four sets of hypnosis programmes will be run every 4 weeks with evening and weekend options
7. The hypnosis scripts will be adapted from those tested in the current Australian Hatch Trial
8. The sessions will include self-hypnosis induction techniques, exercises relating to confidence, coping and strength in labour, suggestions for time distortion, a labour rehearsal involving recurrent fractionation and staircase imagery, and pain control and dissociation techniques. Participants will also be asked to listen to a CD of reinforcement exercises at least once a day until their baby is born

Control group:
'Usual care' will consist of attendance at any antenatal classes usually offered to nulliparous women, and standard clinical care

Women in both groups will be free to request any additional pain relief they require during labour, and this will be emphasised in the information leaflets.
Primary outcome measure(s) Rates of epidural usage in labour for maternal request
Secondary outcome measure(s) 1. Mode of birth and other maternal labour outcomes
2. Neonatal wellbeing
3. Participants preferences relating to hypnosis
4. Anxiety and fear about labour
5. Recall of labour pain
6. Ability to manage labour
7. Satisfaction with self during labour
8. Clinical and psychological morbidity and well-being
9. Economic cost-benefit analysis
10. Experiences of women, their birth companions, and their caregivers
11. Follow up will continue to 6 weeks postnatal
Sources of funding National Institute for Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB) programme (ref: PB-PG-0808-16234)
Trial website
Publications
Contact name Prof  Soo  Downe
  Address Room 116
Brook Building
ReaCH Group
School of Health
University of Central Lancashire
  City/town Preston
  Zip/Postcode PR1 2HE
  Country United Kingdom
  Tel +44 (0)1772 893815
  Email sdowne@uclan.ac.uk
Sponsor East Lancashire Hospitals NHS Trust (UK)
  Address Research and Development Office
Level 3, Royal Blackburn Hospital
Haslingden Road
  City/town Blackburn
  Zip/Postcode BB2 3HH
  Country United Kingdom
  Email Linda.Gregson@elht.nhs.uk
  Sponsor website: http://www.elht.nhs.uk/
Date applied 29/01/2011
Last edited 25/03/2011
Date ISRCTN assigned 25/03/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central